204 related articles for article (PubMed ID: 16698686)
1. CD34+-derived CD11c+ + + BDCA-1+ + CD123+ + DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy.
Ward KA; Stewart LA; Schwarer AP
Cytotherapy; 2006; 8(2):130-40. PubMed ID: 16698686
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
[TBL] [Abstract][Full Text] [Related]
3. Identification of mature and immature human thymic dendritic cells that differentially express HLA-DR and interleukin-3 receptor in vivo.
Schmitt C; Fohrer H; Beaudet S; Palmer P; Alpha MJ; Canque B; Gluckman JC; Dalloul AH
J Leukoc Biol; 2000 Dec; 68(6):836-44. PubMed ID: 11129651
[TBL] [Abstract][Full Text] [Related]
4. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell counts and their subsets during treatment of multiple myeloma.
Kovarova L; Buchler T; Pour L; Zahradova L; Ocadlikova D; Svobodnik A; Penka M; Vorlicek J; Hajek R
Neoplasma; 2007; 54(4):297-303. PubMed ID: 17822319
[TBL] [Abstract][Full Text] [Related]
6. Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics.
Strobl H; Scheinecker C; Riedl E; Csmarits B; Bello-Fernandez C; Pickl WF; Majdic O; Knapp W
J Immunol; 1998 Jul; 161(2):740-8. PubMed ID: 9670950
[TBL] [Abstract][Full Text] [Related]
7. Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.
Ferrari S; Rovati B; Porta C; Alessandrino PE; Bertolini A; Collovà E; Riccardi A; Danova M
Cancer Immunol Immunother; 2003 Jun; 52(6):359-66. PubMed ID: 12664135
[TBL] [Abstract][Full Text] [Related]
8. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response.
Sioud M; Fløisand Y
Eur J Immunol; 2007 Oct; 37(10):2834-46. PubMed ID: 17853407
[TBL] [Abstract][Full Text] [Related]
9. The CMRF58 antibody recognizes a subset of CD123hi dendritic cells in allergen-challenged mucosa.
Vuckovic S; Khalil D; Angel N; Jahnsen F; Hamilton I; Boyce A; Hock B; Hart DN
J Leukoc Biol; 2005 Mar; 77(3):344-51. PubMed ID: 15569693
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells.
Moldenhauer A; Nociari M; Lam G; Salama A; Rafii S; Moore MA
Stem Cells; 2004; 22(2):144-57. PubMed ID: 14990854
[TBL] [Abstract][Full Text] [Related]
11. Absolute values of dendritic cell subsets in bone marrow, cord blood, and peripheral blood enumerated by a novel method.
Szabolcs P; Park KD; Reese M; Marti L; Broadwater G; Kurtzberg J
Stem Cells; 2003; 21(3):296-303. PubMed ID: 12743324
[TBL] [Abstract][Full Text] [Related]
12. Codevelopment of dendritic cells along with erythroid differentiation from human CD34(+) cells by tumor necrosis factor-alpha.
Fukaya H; Xiao W; Inaba K; Suzuki Y; Hirokawa M; Kawabata Y; Komatsuda A; Endo T; Kishimoto H; Takada G; Sawada K
Exp Hematol; 2004 May; 32(5):450-60. PubMed ID: 15145213
[TBL] [Abstract][Full Text] [Related]
13. Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
Chen LL; Ye F; Yu Y; Chen HZ; Zhang WW; Lü WG; Xie X
Gynecol Oncol; 2009 Jan; 112(1):199-204. PubMed ID: 19022493
[TBL] [Abstract][Full Text] [Related]
14. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
[TBL] [Abstract][Full Text] [Related]
15. Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells.
Teleshova N; Jones J; Kenney J; Purcell J; Bohm R; Gettie A; Pope M
J Leukoc Biol; 2004 Jun; 75(6):1102-10. PubMed ID: 15075365
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: interferon-beta induces CD123(+)BDCA2- dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production.
Huang YM; Adikari S; Båve U; Sanna A; Alm G
J Neuroimmunol; 2005 Jan; 158(1-2):204-12. PubMed ID: 15589055
[TBL] [Abstract][Full Text] [Related]
17. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
Van Brussel I; Van Vré EA; De Meyer GR; Vrints CJ; Bosmans JM; Bult H
J Immunol Methods; 2010 Oct; 362(1-2):168-75. PubMed ID: 20888334
[TBL] [Abstract][Full Text] [Related]
18. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
19. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation.
Wang YS; Chi KH; Chu RM
Vet Immunol Immunopathol; 2007 Aug; 118(3-4):186-98. PubMed ID: 17617471
[TBL] [Abstract][Full Text] [Related]
20. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
Arpinati M; Chirumbolo G; Urbini B; Bonifazi F; Bandini G; Saunthararajah Y; Zagnoli A; Stanzani M; Falcioni S; Perrone G; Tura S; Baccarani M; Rondelli D
Biol Blood Marrow Transplant; 2004 Feb; 10(2):106-15. PubMed ID: 14750076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
